Doll et al. and Bersuker et al. discovered that the level of ferroptosis resistance among various cultured human cancer cell lines is correlated with intracellular FSP1 levels, suggesting that the modulation of the FSP1 level may have clinical significance. This evidence concerns the gene AIFM2 and cancer.